SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : ACTM $100 Million Cable Modem Contract with MOT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BOB who wrote (363)12/15/1997 2:08:00 PM
From: Rob Preuss  Read Replies (1) of 1250
 
Old news...

Zacks' still give the same data as in my previous post:
Message 2909353

Here's a summary of the info on analyst ratings that I have:

RATING DATE ANALYST
1. Buy 12/10 AG Edwards
2. Buy 12/10 Raymond James
3. Buy 10/23 Schroder & Co (Stephen Worobel)
4. Buy 10/23 Robertson Stephens (J. Keith Dunne)
5. Market Performer 10/22 Adams, Harkness & Hill (Vernon Essi)

I don't have copies of the first two analysts' 12/10/97 reports.
I do have copies of the other three analysts' reports...

5. Vernon Essi seems the most negative and states:

"We continue to believe ACT has to restore credibility and
confidence in its story with the investment community and
little share appreciation will occur until Q4 results are
reported in late January."

CY97 EPS estimate: $0.75
CY98 EPS estimate: $1.36

"We continue to believe a fair multiple would be about 16
times CY98 earnings. Applying this to our CY98 EPS of
$1.36 gives us a current target price of $22. We would
emphasize that our confidence is not very high on our
$1.36 for FY98 and further diligence is necessary before
we upgrade the shares to reflect this valuation disparity."

4. Keith Dunne gives no target price but is more positive:

CY97 EPS estimate: $0.75
CY98 EPS estimate: $1.50

"Historically, when EMS companies stumble and lose a major
piece of business, the stocks often correct rapidly, but
then work their way back to new hieghts over the next 12-18
months. We expect that scenario to unfold at ACTM, although
we recognize that the investment is more suitable for value
investors or well-diversified, aggressively managed portfolios."

"If management can achieve its current indications for a
snap-back in EPS in 1Q98, we believe patient investors
should be well rewarded for weathering the storm and
increasing holdings."

"We believe the stock should recover over the next 2-3 quarters
given senior management owns over 50% of the company and is
motivated to take the action necessary to return the organization
to industry growth levels. The last time the company lost a major
account (2H95), the stock declined 50%, but almost tripled in
the year following its nadir in December 1995."

==> Note: Robertson Stephens is a Market Maker for ACTM.

3. Stephen Worobel is slightly more optimistic:

CY97 EPS estimate: $ 0.75
CY98 EPS estimate: $ 1.55
Target Price: $31.

"... we believe some weakness may persist in the coming
quarters as its OEM customers work down inventory levels
and the product sell-through picks up."

"We feel the long-term fundementals for ACT Manufacturing are
positive and that it can recover from the current problems.
We have lowered our 12-month target price to $31 from $37.
This assumes a multiple of 20x our 1998 EPS estimate."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext